SP141 has been found to inhibit cancer cell proliferation and induce cell cycle arrest and apoptosis in vitro, and suppresses xenograft tumor growth in vivo, in breast cancer and pancreatic cancer cell lines and animal models, regardless of the p53 status [40,41]. Here, TP53 is linked to breast carcinoma.